Wednesday, October 4, 2023
Wednesday, October 4, 2023

Contact: 561.316.3330

Radcliffe Group Appoints Dr. Peter O’Kane New Editor-in-Chief of Interventional Cardiology Review and Opens Journal to Original Research Through Its Title Change (ICR3)

Radcliffe Group, a STM publisher and digital media producer of cardiovascular, renal, and metabolic content has announced Dr. Peter O’Kane as the new editor-in-chief of their journal, Interventional Cardiology: Reviews, Research, and Resources.

Dr. O’Kane was appointed as a consultant interventional cardiologist at the Royal Bournemouth Hospital in July 2007 and has performed more than 7,000 PCI cases. He has extensive experience with coronary physiology and intra-coronary imaging to guide intervention and the many tools and techniques to manage bifurcations, calcification, and chronic occlusions.

He is committed to teaching and has trained many physicians both in the UK and internationally in devices such as rotational and laser atherectomy and developing technical skills such as those involved in bifurcation stenting and coronary imaging utilization. He has presented at many cardiology conferences and performed as a live case operator. He has contributed to 30 global research studies as a local principal investigator with a high provision of randomized patients and has co-authored more than 50 manuscripts in addition to 10 book chapters.

With such a keen interest in clinical and academic cardiology, Dr. O’Kane is very excited to take this position. “It is a great privilege to accept the position of EiC for ICR3 and work alongside a fantastic team of clinicians, academics, and editors in this well-established publishing house. I will bring my cardiology experience to build on the strong foundations of the journal and develop strategies to promote original research submission whilst maintaining the recognized high quality of reviews and clinical resources that have been synonymous with Radcliffe Group and have undoubtedly guided patient care across the world”, said Dr. O’Kane.

Radcliffe Cardiology would like to thank Dr. Simon Kennon for his editorship of ICR over the last seven years and wish him well. He will continue to remain involved with the ICR journal as an editorial board member, supporting the incumbent Editor-in-Chief.

At the same time, ICR is changing its title to Interventional Cardiology: Reviews, Research, Resources (ICR3) and has now opened to receive submissions of original research. This is the next step in the journal’s development, and we are thrilled about the exciting opportunities to come.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

MORE EXECUTIVES

Renowned Orthopedic Surgeon, Dr. Stephen Hochschuler, Joins Backstop Neural’s Advisory Board

Dr. Stephen Hochschuler is a distinguished figure in the medical field, renowned for his groundbreaking work in orthopedic surgery. With over four decades of experience, Dr. Hochschuler has consistently pushed the boundaries of medical science, contributing significantly to the advancement of surgical techniques and patient care.

Lazurite® Names Dr. Christopher Proctor to its Medical Advisory Board

“We are honored to have Dr. Christopher Proctor join our medical advisory board,” Lazurite CEO and cofounder Eugene Malinskiy said. “He was an early adopter of our ArthroFree® Wireless Surgical Camera System and has provided significant insight into the customer experience of adopting a wireless surgical camera. In addition to his accomplishments as a physician, he has also developed and patented devices, so he understands and appreciates innovation in medicine.”

Broken String Biosciences Strengthens Senior Leadership Team

Bringing significant expertise in their respective fields, Vincent Smith, PhD and Jessica Rich appointments are a key part of Broken String’s strategy to deliver on its Series A goals, which include the continued development of its INDUCE-seq™ DNA break-mapping platform and acceleration of its commercial expansion across global markets.

New Chief Sales Officer at Encare with Focus on Continued Global Expansion

The HealthTech company Encare has recruited Lotta Sellén as the new Chief Sales Officer (CSO). Lotta Sellén has solid experience in the pharmaceutical, healthcare and HealthTech industries.

CorWave Appoints Magalie Durrèche as Chief Financial Officer

Magalie Durrèche will oversee the financial management and participate in the strategic planning and fundraising of CorWave, a company developing and manufacturing a blood pump based on breakthrough technology. She succeeds Zina Hamoumi, who served as Chief Financial Officer for five years before deciding to focus on other projects.

By using this website you agree to accept Medical Device News Magazine Privacy Policy